Retour
Fourchette du Jour
141,64 €
149,76 €
Fourchette 52 Semaines
60,40 €
212,75 €
Volume
3 990 099
Moyenne 50J / 200J
152,68 €
/
147,77 €
Clôture Précédente
136,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -24,3 | 0,4 |
| P/B | 42,0 | 2,9 |
| ROE % | -249,3 | 3,8 |
| Net Margin % | -210,5 | 3,9 |
| Rev Growth 5Y % | 33,9 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Hold
214,47 €
+49.0%
Low: 166,00 €
High: 269,00 €
BPA Prévisionnel
-2,72 €
CA Est.
1,7 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
11,07 €
8,40 € – 14,24 €
|
6,5 B | 6 |
| FY2029 |
8,48 €
6,44 € – 10,91 €
|
5,2 B | 10 |
| FY2028 |
3,97 €
0,90 € – 7,23 €
|
3,9 B | 15 |
Points Clés
Revenue grew 33,93% annually over 5 years — strong growth
Negative free cash flow of -967,58M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 32,80%
Capital efficient — spends only 5,37% of revenue on capex
Croissance
Revenue Growth (5Y)
33,93%
Revenue (1Y)66,73%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-249,28%
ROIC-58,56%
Net Margin-210,54%
Op. Margin-194,04%
Sécurité
Debt / Equity
1,04
Current Ratio3,83
Interest Coverage-14,04
Valorisation
P/E Ratio
-24,31
P/B Ratio42,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 66,73% | Revenue Growth (3Y) | 40,96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33,93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 606,42M | Net Income (TTM) | -1,28B |
| ROE | -249,28% | ROA | -56,38% |
| Gross Margin | 79,41% | Operating Margin | -194,04% |
| Net Margin | -210,54% | Free Cash Flow (TTM) | -967,58M |
| ROIC | -58,56% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,04 | Current Ratio | 3,83 |
| Interest Coverage | -14,04 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -24,31 | P/B Ratio | 42,00 |
| P/S Ratio | 51,18 | PEG Ratio | -1,93 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 31,04B | Enterprise Value | 31,29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 606,42M | 363,71M | 305,21M | 245,36M | 188,46M |
| Net Income | -1,28B | -913,77M | -749,57M | -481,53M | -434,65M |
| EPS (Diluted) | -6,41 | -5,57 | -5,34 | -3,91 | -3,88 |
| Gross Profit | 481,55M | 277,97M | 239,64M | 190,23M | 144,31M |
| Operating Income | -1,18B | -878,25M | -709,63M | -457,32M | -375,09M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,26B | 2,03B | 1,33B | 1,66B | 1,24B |
| Total Liabilities | 1,53B | 1,74B | 1,66B | 1,57B | 833,04M |
| Shareholders' Equity | 738,98M | 285,38M | -331,92M | 87,95M | 410,47M |
| Total Debt | 768,16M | 1,31B | 1,20B | 1,18B | 612,27M |
| Cash & Equivalents | 510,45M | 555,03M | 482,37M | 1,07B | 716,78M |
| Current Assets | 1,79B | 1,62B | 929,06M | 1,27B | 837,04M |
| Current Liabilities | 468,87M | 297,53M | 225,63M | 190,24M | 135,17M |